GBL in Solomon Islands: not individually verified

Also known as: blue nitro

We have not confirmed that GBL specifically is scheduled in Solomon Islands, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record

Not confirmed. No entry for GBL (gamma-butyrolactone) was found in the instruments read. Searched: the Dangerous Drugs Act (Cap. 98) reprint as in force at 1 October 2009 (text); the schedule to the proclamation of 21 September 1987 (LN 101 of 1987) and the further proclamation LN 6 of 1988 (the margin of printed page 2824 reads LN 61/1988, while the heading on page 2821 and the 2025 Rules cite LN 6 of 1988), read from the page images of printed pages 2821 to 2824 of the 1996 Revised Edition; the Pharmacy and Poisons Act (Cap. 105) reprint as in force at 5 February 2024, including Schedule A and Schedule B (the Poisons List, Parts I and II); the Poisons Rules made under section 61 of that Act, as printed in the 1996 Revised Edition (printed pages 3000 to 3043, margin notes amended to LN 63 of 1988), read from the page images, including the First Schedule and the Fourth Schedule of substances sold by retail only on a prescription; and the Dangerous Drugs (Methylamphetamine) Rules 2025 (Gazette No. 158, 5 November 2025). Terms searched: GBL, gamma-butyrolactone, butyrolactone, lactone, GHB, hydroxybutyrate, 1,4-butanediol, butanediol. Result: no entry for GBL, GHB, butyrolactone or butanediol in the proclamation schedules, the Act, the Poisons List or the Fourth Schedule. Nothing in the pages read names a solvent or precursor of this kind. GBL is a lactone, and that it can be converted into GHB is general chemistry that no instrument read states. No instrument read treats a substance as controlled because it can be converted into GHB, and section 13(2) of the Act refers to drugs capable of being changed into drugs productive of effects like morphine or cocaine, a clause this answer does not extend to GBL because nothing read shows GBL to be such a drug. GBL is not treated as reached by the generic limbs in paragraphs 2 to 5 of the 1987 schedule or as excluded from them, because no instrument read states whether it is a stereoisomer, ester, ether or salt of a printed substance; this reading is outside the instruments and no verdict rests on it. The control model for dangerous drugs is delegated. Section 2 of the Dangerous Drugs Act defines a dangerous drug as any of the substances which may be from time to time subject to the provisions of the Act, and section 13(2) lets the Minister by proclamation apply Part III to further drugs. That power has been exercised more than once (LN 101 of 1987, LN 6 of 1988, and the 2025 Rules made under section 15 and those two proclamations). The reprint lists only Act No. 14 of 2009 in its endnotes and carries no line closing its subsidiary legislation, and proclamations or rules made after the 1996 edition were not all read. A Dangerous Drugs (Amendment) Bill 2025 is reported as before Parliament and was not read; a Bill is not law. Absence from the instruments read is therefore not a finding that GBL (gamma-butyrolactone) is uncontrolled, legal or unregulated, and no verdict is given. Not established: whether any instrument not read names it.

Confirm directly with Solomon Islands’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.